CYCLOCORT
LOE ApproachingNDATOPICALLOTION
Approved
Jun 1988
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CYCLOCORT is a topical corticosteroid lotion approved in 1988 for inflammatory skin conditions. The product is a small-molecule corticosteroid formulated for dermatological use via topical application. It functions as a topical anti-inflammatory agent to reduce skin inflammation and associated symptoms.
LOE Approaching
Product is in late-stage lifecycle with moderate competitive pressure (30/100), indicating defensive market positioning and likely focus on retention rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on CYCLOCORT offers experience in mature product management, competitive positioning, and market defense in a crowded therapeutic category. Career growth is moderate; roles focus on operational efficiency and retention rather than innovation or expansion.
Brand ManagerField Sales Representative
Worked on CYCLOCORT at Astellas? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.